Literature DB >> 15175994

Promoting appropriate antibiotic use for pediatric patients: a social ecological framework.

Jennifer Weissman1, Richard E Besser.   

Abstract

During the 1990s, the number of prescriptions for antibiotics for children and adolescents finally decreased after more than a decade of alarming increases. The Centers for Disease Control and Prevention (CDC) and many other groups have designed and implemented interventions to promote appropriate prescribing of antibiotics, and these efforts appear to have contributed to recent decreases in rates of such prescribing. In this article, we describe the various types of interventions that the CDC and others are using to encourage appropriate use of antibiotics. A social ecological framework is used to describe the various factors contributing to prescribing and using antibiotics, as well as the interventions used for targeting these factors. Although most efforts promoting appropriate use of antibiotics have focused on reducing such use for viral infections, future efforts also should include a focus on ensuring the use of targeted agents when antibiotics are indicated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175994     DOI: 10.1053/j.spid.2004.01.004

Source DB:  PubMed          Journal:  Semin Pediatr Infect Dis        ISSN: 1045-1870


  17 in total

1.  Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.

Authors:  F Angoulvant; D Skurnik; H Bellanger; H Abdoul; X Bellettre; L Morin; M Aptecar; G Galli-Gibertini; O Bourdon; C Doit; A Faye; J-C Mercier; R Cohen; C Alberti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

2.  Differences in outpatient antibiotic prescription in Italy's Lombardy region.

Authors:  C Franchi; M Sequi; M Bonati; A Nobili; L Pasina; A Bortolotti; I Fortino; L Merlino; A Clavenna
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

3.  Antibiotic prescribing for pediatric respiratory infections: What explains a large variation among physicians?

Authors:  Rachel McKay; David M Patrick; Kimberlyn McGrail; Michael R Law
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

4.  Antimicrobial prescribing in the USA for adult acute pharyngitis in relation to treatment guidelines.

Authors:  Steven Y Hong; Ying Taur; Michael R Jordan; Christine Wanke
Journal:  J Eval Clin Pract       Date:  2010-06-25       Impact factor: 2.431

5.  Decrease of antibiotic consumption in children with upper respiratory tract infections after implementation of an intervention program in Cyprus.

Authors:  V Papaevangelou; A Rousounides; A Hadjipanagis; A Katsioulis; M Theodoridou; C Hadjichristodoulou
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

6.  Recent trends in outpatient antibiotic use in children.

Authors:  Louise Elaine Vaz; Kenneth P Kleinman; Marsha A Raebel; James D Nordin; Matthew D Lakoma; M Maya Dutta-Linn; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

7.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

Review 8.  Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005.

Authors:  Alessandra Rossignoli; Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2007-09-21       Impact factor: 2.953

Review 9.  Contemporary concepts in management of acute otitis media in children.

Authors:  Eleni Rettig; David E Tunkel
Journal:  Otolaryngol Clin North Am       Date:  2014-08-01       Impact factor: 3.346

10.  Systemic antibiotic use among children and adolescents in Germany: a population-based study.

Authors:  Jakob Holstiege; Edeltraut Garbe
Journal:  Eur J Pediatr       Date:  2013-02-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.